1. Home
  2. LSCC vs HALO Comparison

LSCC vs HALO Comparison

Compare LSCC & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSCC
  • HALO
  • Stock Information
  • Founded
  • LSCC 1983
  • HALO 1998
  • Country
  • LSCC United States
  • HALO United States
  • Employees
  • LSCC N/A
  • HALO N/A
  • Industry
  • LSCC Semiconductors
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LSCC Technology
  • HALO Health Care
  • Exchange
  • LSCC Nasdaq
  • HALO Nasdaq
  • Market Cap
  • LSCC 8.4B
  • HALO 7.4B
  • IPO Year
  • LSCC 1989
  • HALO N/A
  • Fundamental
  • Price
  • LSCC $41.18
  • HALO $58.79
  • Analyst Decision
  • LSCC Strong Buy
  • HALO Buy
  • Analyst Count
  • LSCC 12
  • HALO 9
  • Target Price
  • LSCC $67.08
  • HALO $61.63
  • AVG Volume (30 Days)
  • LSCC 4.1M
  • HALO 1.8M
  • Earning Date
  • LSCC 05-02-2025
  • HALO 05-06-2025
  • Dividend Yield
  • LSCC N/A
  • HALO N/A
  • EPS Growth
  • LSCC N/A
  • HALO 63.33
  • EPS
  • LSCC 0.44
  • HALO 3.43
  • Revenue
  • LSCC $509,401,000.00
  • HALO $1,015,324,000.00
  • Revenue This Year
  • LSCC $4.46
  • HALO $20.06
  • Revenue Next Year
  • LSCC $20.52
  • HALO $24.04
  • P/E Ratio
  • LSCC $93.59
  • HALO $17.14
  • Revenue Growth
  • LSCC N/A
  • HALO 22.44
  • 52 Week Low
  • LSCC $34.69
  • HALO $37.73
  • 52 Week High
  • LSCC $78.85
  • HALO $66.00
  • Technical
  • Relative Strength Index (RSI)
  • LSCC 34.61
  • HALO 44.06
  • Support Level
  • LSCC $39.87
  • HALO $57.50
  • Resistance Level
  • LSCC $45.22
  • HALO $62.14
  • Average True Range (ATR)
  • LSCC 4.17
  • HALO 2.90
  • MACD
  • LSCC -0.28
  • HALO -0.40
  • Stochastic Oscillator
  • LSCC 33.16
  • HALO 36.41

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: